Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark Borris Docdoc Aldonza
Correction: Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells
PLoS ONE
Multidisciplinary
Related publications
Stable Reversal of Multidrug Resistance in Colon Cancer Cells by RNA Interference Targeting the MDR1 Gene
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Co-Suppression of MDR1 (Multidrug Resistance 1) and GCS(glucosylceramide Synthase)restores Sensitivity to Multidrug Resistance Breast Cancer Cells by RNA Interference (RNAi)
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Reversal of Multidrug Resistance by Magnetic Fe3O4 Nanoparticle Copolymerizating Daunorubicin and MDR1 shRNA Expression Vector in Leukemia Cells
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Ceramide and Glucosylceramide Upregulate Expression of the Multidrug Resistance Gene MDR1 in Cancer Cells
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
Cell Biology
Molecular Biology
Cyclooxygenase-Independent Down-Regulation of Multidrug Resistance-Associated Protein-1 Expression by Celecoxib in Human Lung Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein
PLoS ONE
Multidisciplinary
Rapid Determination of Multidrug Resistance-Associated Protein in Cancer Cells by Capillary Electrophoresis Immunoassay
Journal of Chromatography A
Medicine
Organic Chemistry
Analytical Chemistry
Biochemistry
Functional Detection of MDR1/P170 and MRP/P190-mediated Multidrug Resistance in Tumour Cells by Flow Cytometry
British Journal of Cancer
Cancer Research
Oncology
Clinical Reversal of Multidrug Resistance
Oncologist
Cancer Research
Medicine
Oncology